Resident Editor: Kendra Moore, MD, MBE
Faculty Editor: Aparajita Singh, MD, MPH
BOTTOM LINE ✔ Constipation is extremely common but only rarely due to life threatening disease ✔ If feasible, discontinue meds that can cause constipation before considering testing ✔ Add suppository or enema if impacted or severely constipated |
Background
- Constipation is extremely common: prevalence about 16% in adults overall and 33% adults >60
- Cause of 2.5M physician visits and 92,000 hospital visits annually
Diagnostic criteria for functional constipation (Rome IV):
- 2+ of the following for at least 3 months:
- <3 spontaneous BMs per week
- straining during >25% of BMs
- lumpy or hard stools during >25% of BMs
- sensation of incomplete evacuation during >25% of BMs
- sensation of anorectal obstruction for >25% of BMs
- Manuel maneuvers to facilitate >25% of BMs
- Loose stools are rarely present without the use of laxatives
- Insufficient criteria for IBS- consider this particularly if there is recurrent abd pain
DDx:
Types of functional constipation:
- Normal transit (normal frequency but hard stool or straining)
- Slow transit (due to abnormal innervation or visceral myopathy)
- Disorders of defecation: lack of coordination of recto-anal and pelvic muscles
Secondary causes:
- Drugs: including anticholinergics (antihistamines, antispasmodics, antidepressants, and antipsychotics), antacids, iron supplements, opiates, calcium channel blockers, calcium, diuretics, and anti-parkinsonian drugs
- Obstruction: Cancer, strictures, adhesions, rectocele, external compression
- Endocrine: hypothyroidism, diabetes, hyperparathyroidism, panhypopituitarism
- Metabolic: hypercalcemia, hypokalemia hypomagnesemia, uremia
- Neurologic: spinal cord injury, parkinsonism, MS, CVA, Hirschprung
- Psychiatric: depression, anorexia nervosa, physical and sexual abuse
- Miscellaneous: amyloid, scleroderma, immobility
Evaluation
- History – Features of IBS (ie associated with abd pain), features of pelvic floor dysfunction (ie excessive straining, digital manipulation, spending long time evacuating)
- Alarm features (colonoscopy recommended) – GI bleeding, change in stool caliber, weight loss >10 lb, family history of colon cancer, anemia, + FOBT, >50 with acute onset
- Physical – Abdominal palpable mass, rectal exam to r/o mass/impaction, anal sphincter muscle function
- Tests
- In the absence of alarm signs and symptoms only a CBC is necessary. Unless other clinical features warrant otherwise, Chem Panel, TSH are not recommended just for chronic constipation.
- A colonoscopy should not be performed routinely in all patients. Only those with alarm features or those who are due for colon cancer screening should undergo colonoscopy.
- If history is suggestive of pelvic floor dysfunction – refer for ano-rectal manometry (simple test, done without sedation) to confirm the diagnosis.
- These patients may respond well to fiber/laxative but treatment with biofeedback is quite successful (improvement in 70% patients) with training to relax the pelvic floor and restore recto-anal coordination.
- Colonic Transit study done with sitz marker (multiple X rays after swallowing radiopaque markers) usually considered if patients fail medical management and have refractory symptoms
Treatment for primary constipation:
Step 1: lifestyle modifications: increased water and fiber intake, increased exercise. Recommended water intake is 8 cups a day and fiber intake is 25-30g/day. 2/3 of Americans don't get their recommended daily amount of fiber.
In general, the average content of dietary fiber per serving of each of the food groups is:
Fruits and vegetables—1 to 3 grams
Nuts—2 to 3 grams per ounce
Beans, chickpeas, lentils; most berries—4 to 6 grams
White bread, white rice, refined pasta—less than 1 gram
Unrefined grains such as bran, whole wheat bread, brown rice and barley are excellent sources of fiber. Bulgar, barley, quinoa, oatmeal and bran cereals have between 3 and 6 grams per half cup.
Step 2: Add an inexpensive osmotic agent such as polyethylene glycol or milk of magnesia.
Step 3: Add stimulant laxative (eg bisacodyl oral or suppository or glycerine suppositories). Suppositories are preferably administered 30 min before meals to synergize with the gastrocolic response.
Laxative Agents:
Type |
Names |
Time of Onset |
Side effects |
---|---|---|---|
Bulking (MOA: increase stool bullk and GI motility, decrease colonic transit time) |
Bran, psyllium (metamucil, konsyl) methylcellulose (Citrucel), wheat dextran (Benefiber), calcium polycarbophil (FiberCon) |
12-72h |
Bloating, flatulence most common w/ psyllium (increase dose gradually to avoid side effects) |
Surfactant (MOA: Lower surface tension of stool. Found to be inferior to psyllium for effectiveness) |
Docusate (Colace) |
24-48h |
Well tolerated but poor efficacy |
Osmotic Agents (MOA: draw fluid into small bowel lumen) |
polyethylene glycol (Miralax) Milk of magnesia (MOM), sorbitol, lactulose, |
30m-6h for MOM, 24-48h for other agents |
Bloating (lactulose worst offender, seen in 20%) Mag toxicity with MOM (Avoid in renal failure) |
Stimulants (MOA: alter electrolyte transport and increase motor activity) |
Bisacodyl (Dulcolax), senna, sodium picosulfate |
6-12h |
Abd cramps (56% in bisacodyl, 12% in senna) |
Suppository (MOA: local rectal stimulation, most helpful in pelvic floor dysfunction) |
Bisacodyl, glycerin |
30m-1h |
Rectal irritation |
Fluid enemas (MOA: mechanical lavage) |
Tap water enema, phosphate enema (Fleet’s)
|
Usually immediate |
phosphate enema can cause electrolyte imbalance, avoid in elderly and with renal failure, heart failure |
Lubricant (MOA: lubricates stool, not a preferred agent due to side effects) |
Mineral oil |
|
Lipid pneumonia, mal-absorption of fat-soluble vitamins |
Peripheral mu agonist |
Methylnaltrexone |
30-60m |
Diarrhea, abd pain |
Other (only considered for refractory cases due to $$) |
Lubiprostone (Cl channel activator in intestine; Linaclotide (Linzess, increases cGMP to decrease transit time); Plecanatide (Trulance, builds up levels of cGMP); Prucalopride (Resolor, 5HT-4 agonist) |
Daily medication rather than PRN |
Diarrhea (16% in Linzess) |
When to refer: Refractory symptoms, red flag symptoms or symptoms suggestive of pelvic floor dysfunction- refer to gastroenterology for colonoscopy, ano-rectal manometry or colonic transit study
References
American Gastroenterological Association Medical Position Statement: Guidelines on constipation. Gastroenterology 2013:144:211-217
Drossman DA, Hasker WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016; 150:1257–1261.
Jamshed et al. Diagnostic approach to chronic constipation in adults. Am Fam Physician. 2011 Aug 1;84(3):299-306.
Longstreth et al. Functional Bowel Disorders. Gastroenterology. 2006;130 (5):1480
Mounsey et al. Management of constipation in older adults. Am Fam Physician. 2015 Sep 15;92(6):500-504.